KPP Advisory Services LLC Grows Position in Inotiv, Inc. (NASDAQ:NOTV)

KPP Advisory Services LLC raised its position in Inotiv, Inc. (NASDAQ:NOTV) by 15.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 275,267 shares of the company’s stock after acquiring an additional 37,549 shares during the quarter. KPP Advisory Services LLC’s holdings in Inotiv were worth $1,140,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Renaissance Technologies LLC lifted its position in shares of Inotiv by 29.9% during the 2nd quarter. Renaissance Technologies LLC now owns 164,164 shares of the company’s stock worth $273,000 after purchasing an additional 37,800 shares during the last quarter. Geode Capital Management LLC increased its holdings in Inotiv by 7.7% in the third quarter. Geode Capital Management LLC now owns 250,895 shares of the company’s stock valued at $427,000 after buying an additional 18,039 shares during the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. raised its stake in Inotiv by 612.5% in the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 127,257 shares of the company’s stock valued at $527,000 after buying an additional 109,397 shares in the last quarter. Institutional investors and hedge funds own 18.17% of the company’s stock.

Insider Activity

In other news, Director David Landman purchased 23,529 shares of the business’s stock in a transaction on Thursday, December 19th. The shares were bought at an average price of $4.25 per share, with a total value of $99,998.25. Following the completion of the transaction, the director now directly owns 176,851 shares in the company, valued at approximately $751,616.75. This represents a 15.35 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Michael J. Harrington acquired 10,000 shares of the firm’s stock in a transaction dated Friday, December 6th. The stock was purchased at an average cost of $3.98 per share, with a total value of $39,800.00. Following the completion of the acquisition, the director now directly owns 37,500 shares of the company’s stock, valued at approximately $149,250. This trade represents a 36.36 % increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders purchased 71,029 shares of company stock worth $314,248. Corporate insiders own 7.80% of the company’s stock.

Inotiv Stock Down 4.0 %

Shares of NASDAQ NOTV opened at $4.28 on Monday. Inotiv, Inc. has a 1 year low of $1.23 and a 1 year high of $11.42. The company has a market capitalization of $111.32 million, a price-to-earnings ratio of -1.02 and a beta of 3.59. The company has a debt-to-equity ratio of 2.29, a current ratio of 1.37 and a quick ratio of 1.22. The business has a 50-day moving average of $4.37 and a two-hundred day moving average of $2.75.

Inotiv (NASDAQ:NOTV) last posted its earnings results on Tuesday, December 3rd. The company reported ($0.16) earnings per share for the quarter. Inotiv had a negative return on equity of 15.86% and a negative net margin of 22.10%. On average, analysts forecast that Inotiv, Inc. will post -0.75 earnings per share for the current fiscal year.

Inotiv Profile

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.